Individualized Dosing of Selexipag Based on Tolerability in the GRIPHON Study Shows Consistent Efficacy and Safety in Patients With Pulmonary Arterial Hypertension (PAH)
Channick, Richard, Chin, Kelly, Di Scala, Lilla, Frey, Aline, Preiss, Ralph, Gaine, Sean, Galiè, Nazzareno, Ghofrani, Hossein Ardeschir, Hoeper, Marius, Lang, Irene, McLaughlin, Vallerie, Rubin, LewisVolume:
148
Language:
english
Journal:
Chest
DOI:
10.1378/chest.2256760
Date:
October, 2015
File:
PDF, 254 KB
english, 2015